title: Oxaliplatin-induced immune thrombocytopenia in a patient with colon cancer.
authors.affiliation: Department of Medical Oncology, Baskent University School of Medicine, Ankara, Turkey.
authors.forename: Aydan
authors.initials: A
authors.lastname: Akdeniz
authors.forename: Nadire
authors.initials: N
authors.lastname: Kucukoztas
authors.forename: Selim
authors.initials: S
authors.lastname: Yalcin
authors.forename: Zafer
authors.initials: Z
authors.lastname: Akcali
authors.forename: Ozden
authors.initials: O
authors.lastname: Altundag
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D017024:Chemotherapy, Adjuvant; D003082:Colectomy / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects*; D018570:Risk Assessment; D012720:Severity of Illness Index; D012811:Sigmoid Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000276:immunology* / Q000503:physiopathology; D028761:Withholding Treatment
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D011725:Pyridines; C431073:oxiplatin